Cargando…
Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen
In general, a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection. However, to work with highly contagious pathogens, it is necessary to take precautions against laboratory-acquired infection. We have learned many...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122600/ https://www.ncbi.nlm.nih.gov/pubmed/19057880 http://dx.doi.org/10.1007/978-1-59745-181-9_11 |
_version_ | 1783515453689167872 |
---|---|
author | Tsunetsugu-Yokota, Yasuko |
author_facet | Tsunetsugu-Yokota, Yasuko |
author_sort | Tsunetsugu-Yokota, Yasuko |
collection | PubMed |
description | In general, a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection. However, to work with highly contagious pathogens, it is necessary to take precautions against laboratory-acquired infection. We have learned many lessons from the recent outbreak of severe acute respiratory syndrome (SARS). In order to develop an effective vaccine and diagnostic tools, we prepared UV-inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 (BSL3) regulation. Our protocol for large-scale preparation of UV-inactivated SARS-CoV including virus expansion, titration, inactivation, and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future. |
format | Online Article Text |
id | pubmed-7122600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71226002020-04-06 Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen Tsunetsugu-Yokota, Yasuko SARS- and Other Coronaviruses Article In general, a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection. However, to work with highly contagious pathogens, it is necessary to take precautions against laboratory-acquired infection. We have learned many lessons from the recent outbreak of severe acute respiratory syndrome (SARS). In order to develop an effective vaccine and diagnostic tools, we prepared UV-inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 (BSL3) regulation. Our protocol for large-scale preparation of UV-inactivated SARS-CoV including virus expansion, titration, inactivation, and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future. 2007-11-28 /pmc/articles/PMC7122600/ /pubmed/19057880 http://dx.doi.org/10.1007/978-1-59745-181-9_11 Text en © Humana Press, a part of Springer Science+Business Media, LLC 2008 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Tsunetsugu-Yokota, Yasuko Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen |
title | Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen |
title_full | Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen |
title_fullStr | Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen |
title_full_unstemmed | Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen |
title_short | Large-Scale Preparation of UV-Inactivated SARS Coronavirus Virions for Vaccine Antigen |
title_sort | large-scale preparation of uv-inactivated sars coronavirus virions for vaccine antigen |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122600/ https://www.ncbi.nlm.nih.gov/pubmed/19057880 http://dx.doi.org/10.1007/978-1-59745-181-9_11 |
work_keys_str_mv | AT tsunetsuguyokotayasuko largescalepreparationofuvinactivatedsarscoronavirusvirionsforvaccineantigen |